Recombinant DNA molecules research, proposed actions under guidelines; notice.
D026683:Advisory Committees; D003219:Confidentiality; D004274:DNA, Recombinant; D017041:Ethics Committees; D028744:Ethics Committees, Research; D035082:Federal Government; D015316:Genetic Therapy; D006076:Government; D033161:Government Regulation; D017408:Guidelines as Topic; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D009316:National Institutes of Health (U.S.); D018579:Patient Selection; D018907:Privacy; D011640:Public Policy; D012015:Reference Standards; D012107:Research Design; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D014481:United States
Biomedical and Behavioral Research; DHHS Guidelines; Genetics and Reproduction; Legal Approach; NIH Guidelines; National Institutes of Health; Points to Consider; Recombinant DNA Advisory Committee